Let’s get to it withNUCALA. NUCALA is an add-on, prescription maintenance treatment for patients 6 and older with severe eosinophilic asthma. NUCALA is not used to treat sudden breathing problems. Learn about taking NUCALA at home Info about NUCALA sent straight to my inbox? Sign me up. B...
Nucala is used to treat severe eosinophilic asthma, chronic rhinosinusitis with nasal polyps (CRSwNP), eosinophilic granulomatosis with polyangiitis (EGPA), or hypereosinophilic syndrome (HES). It is self-administered by injection subcutaneously (under t
Severe asthma is defined as disease that can only be controlled with high-dose inhaled corticosteroids plus a second maintenance medication and/or systemic corticosteroids, or that remains uncontrolled despite optimal therapy.2 Severe asthma is increasingly recognized as a heterogeneous condition, as ...
In September 2019, the U.S. FDA approved Nucala for use in children as young as 6 years of age who have severe eosinophilic asthma. FDA approval is based on an open-label clinical trial (NCT02377427) which was conducted in 36 children aged 6 to 11 years who have severe asthma. Based ...
May be used as an add-on maintenance treatment for severe eosinophilic asthma in adults and children aged 6 and older. This is a subtype of asthma that is characterized by high numbers of eosinophils in the blood. Eosinophils are a type of white blood cell and this type of asthma affects ...
Severe Asthma Adults And Adolescents Aged 12 Years And Older The recommended dosage of NUCALA in adults and adolescents aged 12 years and older is 100 mg administered once every 4 weeks by subcutaneous injection into the upper arm, thigh, or abdomen [seeDOSAGE AND ADMINISTRATION]. ...